Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Abbott

Status and phase: Completed; Phase 4

Conditions: Hypertension

Treatments: Drug: trandolapril/verapamil

Study type: Interventional

Funder types: Industry

Identifiers

NCT00235001

RUSS-04-01

Details and patient eligibility

About

This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)

Enrollment: 120 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertension

Exclusion criteria

• SBP > 180 mm Hg, DBP > 114 mm Hg
• Subject has a hypersensitivity to trandolapril or verapamil

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

120 participants in 1 patient group

1

Experimental group

Treatment:

Drug: trandolapril/verapamil